Expertise in
1
conditions

Hugues Jeanmart

Montreal, QC, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Montreal, QC, CA 

Overview

Hugues Jeanmart practices practicing medicine in Montreal, Canada.

Mr. Jeanmart is highly rated in 1 condition, according to our data. His clinical expertise encompasses Heart Tumor, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

He is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Montreal, QC, Canada
Other Locations
Canada
Quebec, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Enrollment Status: Recruiting
Publish Date: January 20, 2026
Intervention Type: Drug
Study Drugs: Antiplatelet-only strategy, Anticoagulant+Background antiplatelet therapy
Study Phase: Phase 3
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trial

13 Total Publications

Topical Versus Intravenous Tranexamic Acid in Patients Undergoing Cardiac Surgery: The DEPOSITION Randomized Controlled Trial.
Topical Versus Intravenous Tranexamic Acid in Patients Undergoing Cardiac Surgery: The DEPOSITION Randomized Controlled Trial.
Journal: Circulation
Published: April 08, 2024

Frequently Asked Questions about Hugues Jeanmart

Is Hugues Jeanmart a top-rated expert for Heart Bypass Surgery?

MediFind is an objective health platform that identifies experts based on real-world data. Hugues Jeanmart is classified as an Advanced expert for Heart Bypass Surgery, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hugues Jeanmart participate in research or clinical trials?

Yes. Hugues Jeanmart has published 13 articles and abstracts on conditions like Heart Bypass Surgery. You can view a list of Hugues Jeanmart's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jeanmart's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile